tiprankstipranks
BioInvent International AB (SE:BINV)
:BINV
Sweden Market
BINV
BioInvent International AB
RESEARCH TOOLSreports
Want to see SE:BINV full AI Analyst Report?

BioInvent International AB (BINV) Stock News & Sentiment

2 Followers
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
Premium
Company Announcements
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
4d ago
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
Premium
Company Announcements
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
5d ago
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
Premium
Company Announcements
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
13d ago
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
Premium
Company Announcements
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
13d ago
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
Premium
Company Announcements
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
26d ago
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
Premium
Company Announcements
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
26d ago
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
Premium
Company Announcements
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
26d ago
More SE:BINV News >

BINV News on the Web

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and BioInvent International AB (OtherBOVNF)
TipRanks News
Bullish
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
TipRanks News
Bullish
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
TipRanks News
Bullish
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
TipRanks News
Bullish
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
TipRanks News
Bullish
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
TipRanks News
Neutral
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
TipRanks News
Bullish
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
SE:BINV
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:BINV’s Media Buzz Sentiment?
3 articles about SE:BINV were published this week. In an average week, 1.5 articles are published.
    What is SE:BINV’s weekly average amount of articles?
    In an average week, 1.5 articles about SE:BINV are published.
      What is SE:BINV’s News Sentiment?
      100% of articles about SE:BINV were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week